Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovateltide in Acute Cerebral Ischemic Stroke
NCT05955326Phase 4Active, not recruiting
- Sponsor
- Pharmazz, Inc.
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sovateltide in Acute Ischemic Stroke (AIS), sponsored by Pharmazz, Inc.. Started Jan 2024; status: active, not recruiting.
02
Drugs
sovateltide
03
Conditions
Acute Ischemic Stroke (AIS)
Beyond the preview
Go deeper on NCT05955326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05955326.